Full text of the official published hearing record. Extracted from the source document — verify against the official record for citation.
- CARING FOR SENIORS AMID THE COVID-19 CRISIS [Senate Hearing 116-534] [From the U.S. Government Publishing Office] S. Hrg. 116-534 CARING FOR SENIORS AMID THE COVID-19 CRISIS ======================================================================= HEARING BEFORE THE SPECIAL COMMITTEE ON AGING UNITED STATES SENATE ONE HUNDRED SIXTEENTH CONGRESS SECOND SESSION __________ WASHINGTON, DC __________ MAY 21, 2020 __________ Serial No. 116-19 Printed for the use of the Special Committee on Aging [GRAPHIC NOT AVAILABLE IN TIFF FORMAT] Available via the World Wide Web: http://www.govinfo.gov __________ U.S. GOVERNMENT PUBLISHING OFFICE 47-030 PDF WASHINGTON : 2022 ----------------------------------------------------------------------------------- SPECIAL COMMITTEE ON AGING SUSAN M. COLLINS, Maine, Chairman TIM SCOTT, South Carolina ROBERT P. CASEY, JR., Pennsylvania RICHARD BURR, North Carolina KIRSTEN E. GILLIBRAND, New York MARTHA McSALLY, Arizona RICHARD BLUMENTHAL, Connecticut MARCO RUBIO, Florida ELIZABETH WARREN, Massachusetts JOSH HAWLEY, Missouri DOUG JONES, Alabama MIKE BRAUN, Indiana KYRSTEN SINEMA, Arizona RICK SCOTT, Florida JACKY ROSEN, Nevada ---------- Elizabeth McDonnell, Majority Staff Director Kathryn Mevis, Minority Staff Director C O N T E N T S ---------- Page Opening Statement of Senator Susan M. Collins, Chairman.......... 1 Opening Statement of Senator Robert P. Casey, Jr., Ranking Member 3 PANEL OF WITNESSES Mark J. Mulligan, MD, Director, Division of Infectious Diseases and Immunology, Langone Vaccine Center, Director, Thomas S. Murphy, Sr., Professor, Department of Medicine, New York University Grossman School of Medicine, New York, New York..... 5 R. Tamara Konetzka, Ph.D, Professor of Health Services Research, Department of Health Sciences, University of Chicago, Chicago, Illinois....................................................... 7 Steven H. Landers, MD, MPH, President and CEO, Visiting Nurse Association Health Group, Holmdel, New Jersey.................. 9 APPENDIX Prepared Witness Statements Mark J. Mulligan, MD, Director, Division of Infectious Diseases and Immunology, Langone Vaccine Center, Director, Thomas S. Murphy, Sr., Professor, Department of Medicine, New York University Grossman School of Medicine, New York, New York..... 39 R. Tamara Konetzka, Ph.D, Professor of Health Services Research, Department of Health Sciences, University of Chicago, Chicago, Illinois....................................................... 43 Steven H. Landers, MD, MPH, President and CEO, Visiting Nurse Association Health Group, Holmdel, New Jersey.................. 55 Questions for the Record Mark J. Mulligan, MD, Director, Division of Infectious Diseases and Immunology, Langone Vaccine Center, Director, Thomas S. Murphy, Sr., Professor, Department of Medicine, New York University Grossman School of Medicine, New York, New York..... 59 R. Tamara Konetzka, Ph.D, Professor of Health Services Research, Department of Health Sciences, University of Chicago, Chicago, Illinois....................................................... 59 Additional Statements for the Record American Seniors Housing Association............................. 63 National Adult Protective Services Association................... 69 Community Living Policy Center................................... 71 Leading Age: VNAA Elevating Home................................. 74 Consortium for Citizens with Disabilities, letter dated May 21, 2020, with attachments......................................... 80 The Society for Post-Acute and Long-Term Care Medicine........... 97 Alzheimer's Impact Movement...................................... 102 American Association of Service Coordinators, Janice Monks Statement...................................................... 105 Service Coorinator Response to COVID-19.......................... 109 American Association of Service Coordinators..................... 111 American Health Care Association and The National Center for Assisted Living................................................ 114 CARING FOR SENIORS AMID THE COVID-19 CRISIS ---------- THURSDAY, MAY 21, 2020 U.S. Senate, Special Committee on Aging, Washington, DC. The Committee met, pursuant to notice, at 9:33 a.m., via Cisco WebEx and in Room 301, Russell Senate Office Building, Hon. Susan Collins, Chairman of the Committee, presiding. Present: Senators Collins, Tim Scott, McSally, Braun, Rick Scott, Casey, Gillibrand, Blumenthal, Warren, Jones, and Rosen. OPENING STATEMENT OF SENATOR SUSAN M. COLLINS, CHAIRMAN The Chairman. The hearing of the Senate Special Committee on Aging will come to order. Good morning. Welcome to today's hearing on Caring for Seniors amid the COVID-19 crisis. COVID-19 has brought tremendous hardship and tragedy, placing a heavy burden on the frontline workers, straining our healthcare and distribution systems, and imposing a deadly toll on seniors in particular. It has hit close to home for many on this Committee, and I am sure that all of our members want to join me in expressing our condolences to Senator Elizabeth Warren, who lost her 86-year-old brother to the coronavirus. Elizabeth, we are very sorry for your loss. Restrictions on visitors to nursing homes have affected even those families whose relatives do not have the virus. I know two brothers from Bangor, Maine, whose father is in a nursing home and has dementia. They have not been able to see him for some time now, and his health is failing. They are worried that he may not still be alive by the time they are allowed to visit him, something that used to happen regularly. This virus has already claimed the lives of more than 90,000 Americans, the vast majority of whom were older adults. Adults age 65 years and older are more likely to suffer severe complications from COVID-19 and to have more difficult recoveries. They represent two out of every five hospitalizations and eight out of every ten deaths from the virus. Those in nursing homes and other congregate care centers are especially at risk. Nationwide, nursing home residents represent one-third of all coronavirus deaths. In Maine, the toll on nursing home residents is even higher. Maine is the oldest State in the Nation by median age, and the Centers for Disease Control and Prevention reports 1,819 cases in our State, and the virus has claimed 73 lives. More than half of those deaths have been residents of long-term care facilities, so you can see that Maine has an even higher death toll in nursing homes and other long-term care facilities than the national average. Earlier this month, Senator Sinema and I wrote to the Administrator for the Centers on Medicare and Medicaid outlining a series of recommendations to better protect older adults in nursing homes. Among the issues that we urged be considered is how long-term care facilities and in-home care settings can access adequate testing as well as personal protective equipment and how the higher health risks of older adults living in nursing homes can be taken into account in the distribution plans for any future COVID-19 treatments and vaccines. New diagnostic tests, therapeutics, and vaccines are moving forward at remarkable speeds. I look forward to learning more about this research today as well as promising treatments and strategies that can speed recovery for the most vulnerable populations. Through this and subsequent hearings, I hope that we can gain insight into additional actions that may be needed to better protect our seniors. Congress has already taken a number of actions in response to the pandemic. We have passed four legislative packages totaling nearly $3 trillion to provide public health support to States and economic relief to small businesses and families. Phase 1, provided appropriations to supplement the Strategic National Stockpile; to develop and purchase diagnostics, therapeutics, and vaccines; to support community health centers; and to help hospitals and health systems respond. Phase 2, provided free coronavirus testing and increased Federal funds for Medicaid and other critical safety net programs. Phase 3, known as the CARES Act, provided additional funding to purchase critical protective equipment and testing for the stockpile; new resources for medical professionals on the front lines, to whom we owe a great debt of gratitude; direct aid to States; and economic support for small businesses and their employees through the Paycheck Protection Program. The CARES Act also included the Home Health Care Planning Improvement Act. This is a bill that I have championed for 13 years to allow nurse practitioners and physician assistants to certify home health services. Cutting down on time-consuming, unnecessary paperwork requirements that not only fail to improve patient care, but also delays access to that care, could not have come at a better time. In addition, the CARES Act makes a number of improvements in the delivery of telehealth. More progress is still needed, and I plan to introduce a bill soon to create a framework to reimburse for telehealth services provided by home health agencies. Finally, Phase 4 provided an additional funding for the Paycheck Protection Program, $75 billion for our hospitals, and $25 billion for additional testing. Much of the funding provided through these bills has yet to be released by the Department of Health and Human Services; therefore, I urge the Department to act with urgency so that this funding can flow to areas where it is desperately needed. Today we will hear from a panel of experts who are leading the charge in supporting seniors across a variety of settings of care, including in hospitals, in nursing homes, and in the community. We will be joined by Dr. Mark Mulligan, a physician who serves as the director of the Langone Vaccine Center at New York University; Dr. Tamara Konetzka, a professor of Health Services Research at the University of Chicago whose research focuses on quality of care in long-term care settings; and Dr. Steven Landers, a geriatrician who serves as the president and chief executive officer of the nonprofit Visiting Nurse Association Health Group. I am grateful to each of them for the work that they are doing and for taking the time to join us today. Their expertise will help us advance public policies, to slow the spread of this devastating pandemic, and to lessen its impact on our Nation's vulnerable seniors. Senator Casey, I know you are joining us remotely, and I would now call on you for your opening statement. I also want to acknowledge that Senator Braun has joined us in person at the hearing this morning, and as I said, there are many that are online joining us and we expect others to be here physically as well. Senator Casey? OPENING STATEMENT OF SENATOR ROBERT P. CASEY, JR., RANKING MEMBER Senator Casey. Chairman Collins, you can hear me, I hope. [No response.] Senator Casey. I will assume that you are hearing me. Chairman Collins, thank you for convening this hearing. Our Nation at this point in our history is facing the greatest public health crisis in a century. This terrible virus is causing death and destruction at lightning speed. For seniors, the only thing that is moving faster than the virus itself is fear: the fear of being alone; the fear of contracting the virus; and of course, the fear that comes from isolation and that has every single member of the family worried, worried for our seniors. Thousands of seniors in hospital ICUs and nursing homes are dying scared and alone, with no family and no friends to comfort them in their final moments. Millions of seniors more are at home, isolated from their loved ones and scared to death often to leave the house even to get a bag of groceries. This unprecedented challenge calls for equally unprecedented action. The administration has to do more. Congress has to do more to help our seniors and our families at every turn. It is now May the 21st, and we still have no national testing strategy from the administration. The lack of personal protective equipment continues to put our health care providers and other frontline workers at risk. In turn, this puts every single person they come into contact with, and it also puts at risk the entire community. Nursing home residents make up 0.05 percent of the population, and yet deaths associated with nursing homes and other long-term care settings account for over one-third of all deaths from COVID-19, as Senator Collins just outlined, 0.05 percent of the population yet one-third of the deaths are nursing homes and long-term care settings. Still to this day, we are trying to help those residents and workers in nursing homes with one hand tied behind our backs because the administration is not--is not releasing data on outbreaks in these facilities. This is unconscionable, and the administration needs to act. We have heard promises that by the end of May, they will. We need to see specific evidence that they are changing policy to give families, residents, and workers in nursing homes and other long-term care settings more information. Now, Congress has taken a number of steps, as Chairman Collins outlined. We have added unprecedented amounts of funding to purchase personal protective equipment to keep workers from contracting and transmitting the virus. We have funded efforts to help health care workers and health providers help patients in those settings. We have provided dollars to ensure that seniors have access to proper nutrition at home but not nearly enough. The policies and funding in these four bills that we have passed into law only begin to scratch the surface. Congress has to do more. Just last week, the House of Representatives passed the HEROES Act, and that legislation, among many things it does, calls for policies that I have been calling for since the beginning of this crisis, especially as it relates to seniors. It would require, the bill would, nursing homes to collect data on the impact of the virus on residents in nursing homes and other long-term care facilities so that we know how to distribute resources. The bill would also provide those nursing homes the dollars they need to contain the spread of the virus. The bill would also invest in home-and community-based services for seniors and people with disabilities, especially the 800,000 seniors and people with disabilities on waiting lists for care so that they can receive the services and the supports that they need to keep them out of congregate settings. This bill would also pay our essential frontline workers for leaving the safety of their home to care for our aging loved ones. For the generation that has fought our wars and worked in our factories and taught our children and build the middle class, built the Nation that we have, and gave each of us life and love, we have to do more for our seniors. We cannot stop working. We cannot stop legislating. We cannot stop appropriating dollars to help our seniors. We owe it to them to do everything we can. There is no such thing here as doing too much for our seniors in the grip of this pandemic. Chairman Collins, I want to thank you for convening this critically important hearing, the first hearing in Congress on the impact of COVID-19 on seniors, and I look forward to the testimony from our witnesses as well as the questions. Thank you. The Chairman. Thank you very much, Senator Casey. For those of you who are watching us on C-SPAN, I want to explain that this room is specially configured in line with the social distancing recommendations of the CDC, which is why you see so many blank spaces, and again, we have several members who have already joined us remotely. I see Senator Josh Hawley. I see Senator Rick Scott, and there are others as well, some more who will be coming physically as well. There are also many other members whose pictures I cannot see but who have joined us at the hearing. I wanted to explain that this is one of only three hearing rooms that is configured to allow us to hold hearings. I see Senator Blumenthal has also arrived, and I want to acknowledge him as well. We are now going to move to our witnesses. Our first witness, Dr. Mark Mulligan, is joining us from New York University. Dr. Mulligan is the director of the Division of Infectious Diseases at the NYU Grossman School of Medicine, and director, as I have mentioned previously, of the university's Vaccine Center. He is a professor of medicine and a professor of microbiology at NYU. As the chief infectious disease specialist for NYU, he oversees the treatment of COVID-19 patients at the university's health system hospitals in Brooklyn, Long Island, Manhattan, Bellevue, and the VA. Next, we will hear from Dr. Tamara Konetzka. Dr. Konetzka is a professor of health services research at the Department of Health Sciences at the University of Chicago. Her research focuses on the relationship between economic incentives and the quality of care in long-term care facilities. She is leading work to untangle factors associated with the disproportionate impact of COVID-19 on nursing home residents and staff. Finally, we will hear from Dr. Steven Landers, the president and CEO of the Visiting Nurse Association Health Group. VNA is the Nation's second largest not-for-profit home health care organization in the country. Dr. Landers is a family doctor and a geriatrician with a special interest in home care, hospice, and palliative care. He focuses on home visits to low-mobility older adults and has played a critical role in caring for seniors during this pandemic. Dr. Mulligan, we will begin with you. Thank you all for being here. STATEMENT OF MARK J. MULLIGAN, MD, DIRECTOR, DIVISION OF INFECTIOUS DISEASES AND IMMUNOLOGY, LANGONE VACCINE CENTER, DIRECTOR, THOMAS S. MURPHY, SR., PROFESSOR, DEPARTMENT OF MEDICINE, NEW YORK UNIVERSITY GROSSMAN SCHOOL OF MEDICINE, NEW YORK, NEW YORK Dr. Mulligan. Well, good morning, Chairman Collins, Ranking Member Casey, members of the Special Committee on Aging, and fellow witnesses. I also wanted to mention I am an NIH-funded investigator working with the New York University Vaccine and Treatment Evaluation Unit, part of a new NIAID-funded network, focusing on infectious diseases, clinical research, and including work on seniors. This is a very important part of the work that I do as the clinical investigator. This novel coronavirus emerged 5 months ago in China and rapidly led to the global pandemic that we now find ourselves combating. The human population, unfortunately, is highly susceptible; that is, we are non-immune to this virus. Most of us have been exposed to four distant cousins, seasonal co- viruses that are also coronaviruses, but unfortunately, they do not provide cross-protective immunity against the current virus. For physicians, scientists, and leaders, the virus has continued to humble us. There is so much we do not know yet about diagnosis prevention and treatment, about medical countermeasures that will keep us all safe, but that is an important part of what I will be discussing today. Seniors are at increased risk due to the inexorable waning of the immune system, something called ``immunosenescence.'' It is not only their age, however, that renders seniors less able to mount protective immunity against microbial threats, including this coronavirus. It is also the chronic health conditions that are present more frequently in seniors such as cancer; immunosuppression; chronic heart, lung, and kidney diseases; and diabetes. The highest risk for critical disease due to this coronavirus is seen in the frail elderly, those that reside in nursing homes and long-term care facilities. The nurses, the doctors that I have worked with in the hospitals since late February taking care of patients are incredibly dedicated and caring. It is very moving to see how much they put into their jobs to help their patients, and yet, it has been a struggle. They have not had the medical countermeasures they have needed, particularly to help seniors fight this virus. Certain work for residential settings with less effective social distancing, the long-term care facilities we have talked about, factories, have had the worst outbreaks of COVID-19, and we have heard that while just 11 percent of COVID-19 infections in the U.S. have been in nursing homes, one-third of the deaths or perhaps more once we get good data have occurred in nursing homes or nursing home residents. Our main weapons to fight the virus continue to be non- pharmaceutical interventions, all of the social distancing. We know that these work, and they are effective, and they have provided a strong benefit to society and individuals by reducing spread of the virus. However, they come as a cost to the economy, to society, and to the human existence. Therefore, a very important additional category are the Medical Countermeasures, which I will now talk about. A vaccine holds out the promise of immune-protection; that is, producing an immunity within our bodies that will protect us against the virus upon some future exposure with the virus. Safe vaccines have always been our most important weapons to battle infectious diseases with public health importance. Just 2 days ago, the first early report of a COVID-19 vaccine appears, and thank goodness, it was promising. There is a long road ahead for development of safe, effective COVID-19 vaccines, but it was great to have a very positive early signal. Seniors will be included in the all-important efficacy trials that are planned to be supported by the U.S. Government. However, the elderly do not respond as well to vaccines as younger adults do, so the approach of providing a monoclonal antibody as a pre-formed drug for treatment or prevention in seniors is one that is attractive. One U.S. Government and industry partnership that is under way is to move as quickly as possible with a randomized controlled trial of a monoclonal antibody that would be delivered to nursing home residents and nursing home workers in order to try to get control of outbreaks. The highest-quality medical research comes from randomized controlled trials. They provide the answer: Does the treatment work? For one antiviral drug, remdesivir, preliminary information from a randomized controlled trial of remdesivir versus placebo in hospitalized COVID-19 patients, including seniors, revealed a modest benefit, a 31 percent reduction in time to recovery. This is modest but significant and a much needed first signal that we have an effective approach to begin to start to battle this virus. Testing must be continued and increased. It provides a benefit. It allows us to identify those with infection. Until they recover, it can be isolated and thereby reduce further spread of the virus. The more we test, the more we can fight the virus. I will close by saying that the non-pharmaceutical interventions we have deployed against the virus have been highly beneficial, and this remains doubly important for protecting our very vulnerable seniors as we await further development of medical countermeasures, including vaccines and treatments and broader testing. Medical countermeasures may need to be tailored specifically for seniors, given their differences in their biologies. I thank the Committee for the excellent work they are doing. The Chairman. Thank you very much, Doctor. Dr. Konetzka? STATEMENT OF R. TAMARA KONETZKA, Ph.D, PROFESSOR OF HEALTH SERVICES RESEARCH, DEPARTMENT OF HEALTH SCIENCES, UNIVERSITY OF CHICAGO, CHICAGO, ILLINOIS Dr. Konetzka. Chairman Collins, Ranking Member Casey, and distinguished members of the Committee, thank you for the opportunity to testify today. My name is Tamara Konetzka. I am a professor of health economics and health services research at the University of Chicago, and I have been researching long-term and post-acute care for 25 years, often focusing on nursing home quality. The central role of nursing homes in the COVID-19 pandemic has become increasingly clear. Just a month ago, nursing homes staff and residents were estimated to account for one-fifth of all deaths. The estimate is now at least one-third nationally and, as Senator Collins noted, more than half in many States. In some ways, these high rates are not surprising. Nursing homes provide hours of hands-on care daily to large numbers of people with underlying health conditions living in close quarters. Facilities are often understaffed, a situation that has been exacerbated by the pandemic. Nursing homes compete with hospitals for both testing and PPE, which are still in short supply in many areas, but is the spread of COVID-19 in nursing homes inevitable, or have some types of nursing homes managed better than others to manage outbreaks? We set out to answer that question using data on nursing homes from 12 geographically diverse States. We merged State lists of reported COVID-19 cases and deaths with data on nursing home characteristics, including data from nursing home house car, a five-star rating system published by CMS. We calculated the percentage of nursing homes with at least one case or death by star readings, profit status, and several resident characteristics. Our analysis revealed three key results. First, we found a strong and consistent relationship between race and the probability of COVID-19 cases and deaths. Nursing homes with the lowest percent white residents were more than twice as likely to have cases or deaths as those with the highest percent white residents. Second, we found no meaningful relationship between the nursing home five-star ratings and the probability of at least one case or death. In fact, even the direction of the relationship was inconsistent from State to State. Third, we found no difference between for-profit and nonprofit facilities and only a weak relationship with percent of residents on Medicaid. We concluded from this analysis that while some nursing homes undoubtedly had better infection control practices than others, the enormity of this pandemic coupled with the inherent vulnerability of the nursing home setting left even the highest-quality nursing homes largely unprepared, and yet the pattern is not random. Nursing homes are often a reflection of the neighborhoods in which they are located. Consistent with the pandemic generally, nursing homes with traditionally underserved, non-white populations are bearing the worst outcomes. Turning to solutions, it is increasingly clear that long- term care facilities must be a top priority in fighting the pandemic, as that is where the deaths are, and we would suggest several short-term measures. First, nursing homes need a direct influx of funding and technical assistance in order to achieve adequate numbers of staff, availability, and proper use of PPE, and regular and rapid testing of all nursing home residents and staff to enable separation. Second, we need to enhance the ability of Medicaid beneficiaries to receive home-based services instead of institutional services. The decision between care at home or in a nursing home is difficult for families in the best of times. Now the risks and benefits have likely shifted. To best help families in this situation, resources need to be directed toward enabling them to avoid institutionalization during this high-risk time. Third, data collection and transparency about cases and deaths are essential. Timely reporting enables resources to be directed where they are needed most, and at the same time, older adults and their families need this information in order to make their own best decisions, decisions that may be about life or death. These short-term measures are urgent and necessary, but they do nothing to change the underlying systemic challenges to improving the quality of nursing home care and the lives of older adults who live in them. Nursing home residents are ill- equipped to monitor their own care, to advocate for themselves, or to exert political influence. This makes regulation and oversight necessary. Some regulations have been relaxed during this pandemic, but it will be important to reinstate them once the crisis has passed, with increased attention to infection control practices, but the effectiveness of regulation is limited when the structure of nursing home payment is fragmented, uneven, and leads to systematic underfunding of essential services. Those of us who study long-term care are accustomed to hoping for fundamental change and not seeing it. One positive outcome of a severe financial fallout from the pandemic may be that it forces a fundamental reevaluation of how we pay for long-term care in the U.S. Thank you for the opportunity to provide input on this very critical issue. The Chairman. Thank you very much for your excellent testimony. Dr. Landers? STATEMENT OF STEVEN H. LANDERS, MD, MPH, PRESIDENT AND CEO, VISITING NURSE ASSOCIATION HEALTH GROUP, HOLMDEL, NEW JERSEY Dr. Landers. Good morning. Chairman Collins, Ranking Member Casey, members of the Senate Committee on Aging, I am Steve Landers. I am a family doctor and geriatric medicine physician. My clinical work focuses on house calls to homebound seniors, and I serve as the president and chief executive officer for Visiting Nurse Association Health Group. We are a large nonprofit home health and hospice agency headquartered in New Jersey, and we serve parts of Ohio and Florida as well. Our team of 3,000 dedicated caregivers, they have really stepped up during this crisis to help medically fragile older adults come home from hospitals and nursing facilities and, in some cases, never have to go in the hospital in the first place. We serve 9,000 people in our programs and services, and we have taken care of over 650 older adults in the home care setting with known COVID-19 infection. I have never seen the system so stressed and at the same time never felt more proud of the incredible people that I work with every day. One of the reasons we have been able to keep serving has, frankly, been because of Chairman Collins and colleagues, your leadership, in the CARES Act, the provider relief fund. Some of the measures that CMS have taken have been important because our revenues have gone down because of the cancellation of elective medical procedures, and at the same time, expenses related to personal protective equipment, or PPE, testing, those expenses have gone up, so that financial support has been critical. I want to thank you, Chairman Collins and colleagues, for your leadership, advancing the role of nurse practitioners and physician assistants in home-based elder care. Homebound older adults have had limited access to medical care. COVID-19 has made it even harder, and that extension of the team with the nurse practitioners and physician assistants is very important in preserving access, and also the other measures related to the geriatric workforce that were in the CARES Act are very important. I have been reminded again of the incredible difference that home health and hospice can make on quality, compassion, patient safety, and we have seen the stress that hospitals in terms of bed capacity, emergency rooms, nursing facilities, the challenges that they faced and it is highlighted, the need for a strong home care option, an option to home care really when it is at its best working in concert with hospitals, physicians, and nursing facilities to deliver coordinated care. In order for us to provide that option, job number one, is protecting our treasured frontline caregivers. We have been able to maintain care because we have been able to maintain a supply of PPE. Now, that has been incredibly difficult to do. We are using, in my organization, 17,000 surgical masks a week, 3,500 N95s a week, thousands of isolation gowns and goggles, and we have to pay seven to ten times the normal price and use vendors really from all over the world that we could not always vet and verify, just hoping the shipments would arrive, so going forward, I would encourage us to look at policies that could make sure home health agencies have the needed PPE at a reasonable price, also important to our ability to serve during this crisis has been our spirit of innovation. We have really embraced the use of telehealth and virtual visits within our home health agency in order to help people stay safely at home during this crisis. For the COVID-19 home-care patients, they need monitoring of vital signs, oxygen, and respiratory assessment, and so even though home health agencies are not reimbursed for telehealth, we felt that that was important. We also had seen even before this crisis that telehealth could play an important role in home health, and we have been trying to advance that. I think going forward, to make sure we have a strong home health option for older Americans, that finding a way to reimburse telehealth services within home health agencies is really important, also preserving the ability for physicians and nurse practitioners to do the face- to-face encounter and certifies people for home health via telehealth is really important. I really thank you for including me in the hearing this morning, and I am very sad about all the death and suffering but also optimistic that we can strengthen home care and elder care for older American, so thank you. The Chairman. Thank you very much, Doctor. I want to note that Senator Tim Scott and Senator Martha McSally have also joined us in person physically today. What we are going to do, because there were many people who logged on at the very beginning, is we are just going to go in order of seniority. I cannot figure out any other way to do this, given the people who have showed up physically, but also the people who have been online at the very beginning of the hearing. Usually, I would like to reward those who show up first, but I think since there were people online, as I said, I cannot figure out any other way to do this fairly. Let me begin with my own questions, and then Senator Casey will question next remotely. First of all, when we hear the statistics, which are so devastating, with half of the deaths in Maine being in long- term care facility, a third nationally, my heart just goes out not only to the patients, but to their families and to the staff of nursing homes and other assisted living facilities, congregate care settings. They are all praying that COVID-19 does not find its way into their facility. Yesterday the Government Accountability Office released a report that found that nearly half of the more than 13,000 nursing facilities surveyed had infection control deficiency citations in consecutive years, which the report called an indicator of persistent problems, yet as Dr. Konetzka said in her testimony, even the highest-quality nursing homes have been largely unprepared. What we have usually looked at, the ratings by CMS, the number of stars, has not proven to be a reliable indicator of which nursing homes are safest in this environment, and indeed, one of the worst outbreaks in Maine was at a nursing home that had five stars. I think what we are learning is that health care providers are rethinking some of their initial assumptions, and that we need to think more about hospital discharge planning. Dr. Konetzka, I want to have you expand a little bit more on what we can do. I believe that you recommended universal testing for every nursing home resident and staff, which I think is a good idea and have been recommending. How often, however, would you have to do that, and would that allow family members who have been tested to finally be able to visit their loved ones? [No response.] The Chairman. I hope we can unmute Dr. Konetzka because I can see that she is responding, but we cannot hear her. Doctor, go ahead. Dr. Konetzka. Can you hear me? The Chairman. Yes. Thank you. Dr. Konetzka. Okay, great. Yes. Thank you for that question. I think that we are learning a lot as we go about how best to fight this virus in nursing homes, and so we do not have, unfortunately, great data yet on exactly what testing strategies have been used and how successful they have been. A lot of what we are going on is anecdotal evidence, but what I can say is that there have been a few key lessons learned. One is that it is very important to test all residents and not wait until residents are asymptomatic--I mean until residents are symptomatic because by then it is too late. There is asymptomatic spread, and given the close proximity and the fact that staff go from resident to resident every day, the virus, until people get symptomatic, can spread throughout the facility, so we have learned that lesson, that all residents really should be tested, and not only tested but tested regularly. What I have heard from geriatricians is, generally, weekly would be good, at least biweekly, so that residents can then be separated, and the transmission can be stopped. I think it might be very hard especially as we relax some of the restrictions on visitors, which is essential, as you mentioned, essential to prevent the sense of social isolation among our seniors. As we lax those restrictions, it is going to be very hard to prevent all cases in the nursing home. The key then is sort of a rapid response to prevent transmission to the rest of residents and staff. The Chairman. Thank you. Dr. Landers, I appreciate you talking to us about the importance of home care, and that can help people be safer. I have always been a strong supporter of home care. One issue that we have is that people who are older are being increasingly isolated, and that too can have a very detrimental impact on their underlying health and, thus, make them more vulnerable to the coronavirus. Could you comment on how home health visits can help keep a senior more connected and less isolated? Dr. Landers. Chairman Collins, absolutely, home health is a way to show people that they are known and worth something, that they are valued. It is an act of humility, really, and in this crisis, it has been even more important. Sometimes our nurses are the only people that are even checking in on a frail elder, and I have heard them tell stories of having to kind of go out and make sure that the person had a food supply or undergarments or other things that are essential, so the isolation is critical. I think your focus on telehealth also adds, although it is not perfect, making sure that those people that are homebound and need home health also have access in between the visits to some interaction via telehealth but also improve the amount of attention that our older patients are getting. It is a really crisis in sort of loneliness and isolation, so we are trying to do all we can. The Chairman. Thank you. Senator Casey? Senator Casey. Chairman Collins, thanks very much. I wanted to start my questions with Dr. Konetzka. I have a particular question for Dr. Konetzka regarding nursing homes. We know that nursing homes have become, unfortunately, Ground Zero in this pandemic, and yet there is still no national strategy. I believe and I think the testimony today indicated in part that there is still an insufficient supply of personal protective equipment for nursing home staff. These are among the heroes in our society, literally soldiers on a battlefield in a war against the virus, and they are putting themselves at risk for the disease, contracting the virus. They are also putting themselves at risk for death itself, and that includes their families. The word ``hero'' definitely applies to these health care workers. They need, I believe, simply more leadership out of the administration and Congress, more help. They do not need pats on the back only and expressions of gratitude and acclamation. That is nice. What they need is direct support and more than that. I will start with the support for what they do on the job. The most important thing, one of the most important things we can do is to help them implementing what the public health experts tell us are proven practices. I have been asking the administration, first and foremost, for data. The Centers on Medicare and Medicaid Services and CDC, of course, are the ones that would have to transmit this data to the American people. We are talking about basic information on case counts, basic information on deaths, so that we can direct and target the resources to the nursing homes that need it the most. Now, they have said, as I indicated earlier, that it is coming by the end of May, but we have been hearing that for a long time. I have introduced legislation that would focus specifically on nursing homes and other long-term care settings. This particular bill, the Nursing Home COVID-19 Protection and Prevention Act, that I introduced with Senator Whitehouse and a number of our colleagues has as its focus $20 billion in emergency funding to invest in what works. We know that in nursing homes, if you have cohorting, you separate the residents with COVID-19 from those who do not have the virus. That is a good practice, but that costs money. We have got to help them with that. Other uses for the dollars could be charging of medical expertise into a nursing home. Dr. Konetzka, I would ask you, I guess, two basic questions. Why is it so important that we have basic data on COVID-19 in nursing homes? That is question number one, data and question number two is, What are some of the policies that we can use to help nursing homes put in place information, this information in the ample resources? Dr. Konetzka. Thank you, Senator Casey, for that question. As I touched on in my responsibility, I think data and transparency are critically important in this crisis. I think often during a crisis, we are tempted to downplay the need for a collection of data and prioritize other actions, but it is essential in this case for three main reasons. One, we do need to know where resources need to be directed. We know where there are outbreaks in nursing homes. We can direct resources to them, but we can also identify the communities in which the virus is probably spreading. Second, as we look back on this crisis, we need data in order to do the hard research to figure out what works and what did not work so that we can make better policies in the future, and, third, consumers and their families really need to have this information. Anybody looking for a nursing home placement right now or worried about their loved one in a nursing home right now really needs to be able to know what is going on in a very timely way so that they can make their best decisions. In terms of the exact resources, I think a lot of it is about staffing, and we have had a problem with chronic understaffing in nursing homes, and the kind of resources that could help most on an emergency basis for a facility that has an outbreak is to strategize to ensure enough staff. This means providing paid sick leave. This means providing adequate PPE, basically putting nursing home staff on a par with what we naturally want to provide for hospital staff. It is the same situation. Senator Casey. Well, thanks very much. I know I am almost out of time, and Chairman Collins has been generous with our time. I will just ask Dr. Landers a quick question about our frontline heroes. A number of us in the Senate--and I know this is true in the House as well--have made it a focus to create a Heroes Fund, some manifestation of our gratitude for those who have put themselves at risk on the front lines. I know that in the case of Dr. Landers, I am told that you have, in fact, kind of stood up and taken a lead on this, that approximately 50 of your employees have volunteered to help care for patients who have tested positive for COVID-19, and I understand in recognition of their work, you are providing these individuals with additional compensation, so we commend you for that. I guess the basic question is simple. It is a yes or no answer. If the Federal Government provided you with the option to receive funding to provide what we can pandemic premium pay for essential workers and the work they have done in this pandemic, would you apply for the funding? Dr. Landers. Senator Casey, thank you. Yes, we are trying to do all we can to support our frontline heroes, and if there is something we were eligible for and the criteria were appropriate, we would certainly do so. Senator Casey. Thank you. The Chairman. Thank you. Senator Tim Scott? Senator Tim Scott. Thank you, Chairman Collins, Chairwoman Collins. I will say this. Your leadership, Chairwoman, has been spectacular. The Chairman. Thank you. Senator Tim Scott. From the aging community to the Paycheck Protection Program and to this hearing, you consistently show up for the seniors in Maine and the seniors in America, for the small businesses. How you accomplish all that you do, I am not sure, but you are one of the hardest-working, most dedicated public servants I have met. Thank you for this hearing and the opportunity to discuss this incredibly vital issue of protecting our aging communities, which I am closer and closer being a part of, so thank you very much. The Chairman. Thank you so much for your kind words. Senator Tim Scott. To the panel, I will just say this, that without any question, if you are in South Carolina or most of our States, what you will realize very quickly is that those diagnosed with COVID-19 on average is just over 50 years old who are hospitalized, and those who die from the disease in South Carolina is just over 50--over 75 years old. In fact, nearly 90 percent of fatalities in my State, South Carolina, have been from those over the age of 60. It is one of the reasons why I highlighted Senator Collins' dedication to this issue because one-third of all COVID-19 deaths in South Carolina happen in a nursing home or another senior care facility. This is an incredibly important issue and an incredibly timely hearing. In other States, the numbers are even worse than in South Carolina. That said, there have been some encouraging numbers recently, and our Governor in South Carolina and, frankly, Governors around the Nation--I would like to highlight the Governor in Florida as well, DeSantis, who decided to focus the attention on the nursing homes. It is exactly where we should start this challenge, of how we should face this challenge, by focusing on the most vulnerable populations. I have often thought about how important it is for us to recognize that nursing homes are the epicenter of activity. The folks who take care of the patients are disproportionately minorities, African Americans, who have perhaps the second most vulnerable population in our Nation. If you think about States like Louisiana, where 70 percent of the deaths are African Americans, only 33 percent of the population; in my home State, 53 percent of the deaths, African Americans, only 27 percent of the population, so you have one vulnerable community being served by another vulnerable community, and that only highlights the importance of testing, testing, testing in our nursing home facilities. I am thankful that in South Carolina that the 40,000 nursing home residents will be tested between now and the end of June. I am thankful that in South Carolina, we will have over 220,000 tests completed in May and in June of residents of South Carolina, 60,000 already tested so far this month. These are encouraging numbers, and it is one of the reasons why I have introduced legislation to make this the model for the Nation, that our Nation should take serious, testing first in our nursing homes and providing more resources for the vulnerable populations in this country. Along those lines, I have encouraged HHS to set aside a robust share of the Provider Relief Fund that we appropriated through the CARES Act along with $25 billion that we dedicated to testing specifically for nursing homes and community residential care facilities. They need the resources, the supplies, and tests as soon as possible. My question to the full panel, beyond funding, what steps should we be taking at every level of government to help these providers and communities develop the tools and strategies necessary to detect, isolate, and address cases where they occur without straining existing resources by increasing administrative burdens? Dr. Konetzka. If I may answer one part of that, I think in addition to funding, technical assistance to nursing homes is essential because I think sometimes just providing the funding for it does not mean that nursing homes will necessarily know what we are learning about the best practices in terms of actually stemming an outbreak. I think to the extent that local public health departments, State organizations can provide technical assistance and as well as the funding and the resources like surge teams to stem an outbreak, that would be helpful. Dr. Mulligan. Senator Scott, I was just going to add that the importance of clinical research in seniors in nursing homes, educating families, because they are often legally authorized representatives, about clinical research, everything in our medicine cabinet is there because we have conducted clinical research, and we absolutely need to include seniors in our vaccine trials, which we will be launching in large numbers in July, as well as in special senior-focused studies, such as the monoclonal antibodies, to go into nursing homes and provide this option to participate in research. The Chairman. Thank you, Senator. Senator Gillibrand is joining us remotely, and she is next. Senator Gillibrand. Madam Chairman, can you skip me? I am having a technical problem. I just need 5 more minutes, so do the next person. The Chairman. Absolutely. Let me just check on your side of the aisle, and it is Senator Blumenthal, who is right here. Senator Blumenthal. Thank you, Madam Chair. Thank you, Senator Collins and Senator Casey, for bringing us together on this supremely important topic. I was listening to my colleagues, I could not help but remember last Monday when I accompanied Senior Pastor Patrick Collins in a ritual that he has done literally every morning. He places white flags on the lawn in front of the First Congregational Church in Greenwich, Connecticut, and I accompanied him last Monday as we together placed 69 new flags for each COVID-19 death in the State of Connecticut. On Tuesday, the day afterwards, Pastor Collins placed 41 more flags, yesterday 23. Right now, literally as we hold this hearing, exactly to the moment, Pastor Collins is almost certainly placing another 57 new white flags, adding to this sea of markers in front of the First Congregational Church in Greenwich. Every one of those flags represents a life and the thousands of lives lost around the country. Seventy percent of them are seniors, seven in ten, and many are in nursing homes, so the obligation that we have to these vulnerable individuals is brought home very dramatically and graphically by that picture worth a thousand words, literally. That is why I have supported the hazardous duty pay, the Heroes Fund for our nursing home workers, who all too often are risking their lives and making financial sacrifices, and it is more than just rewarding or recognizing them. It is also to retain them and to recruit new nursing home workers. Let me ask, first of all, Dr. Konetzka a question. Is not it a fact that all too often, the employees of these nursing homes are underpaid for the risky and back-breaking work that they do? Dr. Konetzka. That is exactly right. Nursing home workers, especially nursing aides, are generally paid minimum wage, often have no paid sick leave, and often have no health insurance. It is natural that in normal circumstances, nursing homes have a hard time staffing adequately, but under these circumstances where staff are also afraid to get sick, afraid to bring the virus home to their families, or on the other hand may show up to work because they do not have paid sick leave, even though they are feeling ill, I think that all contributes to the issues we are seeing in nursing homes and the understaffing problem in particular. Senator Blumenthal. One of our nursing homes run by a friend of mine, Tyson Belanger, provides living facilities for the nursing home employees on the premises, so they are protected. They have to live away from their families, but they are sealed away from possible infection. The result has been to greatly reduce the incidence of infection. Is that kind of innovation, Dr. Konetzka, a possible promising route that others should follow? Dr. Konetzka. Yes, certainly. I think that nursing home workers should have the option of having a different place to stay, whether that is provided by the nursing home or, like many cities have done for hospital workers, perhaps providing them with unused hotel rooms, so that they have the choice of not risking infecting their families. Senator Blumenthal. Tyson Belanger, by the way, happens to be a veteran, having served multiple tours in the Afghanistan and Iraq Wars. I have introduced legislation with Senator Booker. It is called the Quality Care for Nursing Home Residents and Workers During COVID-19 Act. It would immediately address some of these same problems, not just more testing. In fact, it would require weekly testing of every resident and testing before every shift for health care workers. It would mandate that all health care workers have sufficient PPE and comprehensive safety training for dealing with COVID-19, and that each facility have a full- time infection control preventionist on staff to keep residents and workers safe. It would guarantee that sufficient staff is available to facilitate weekly virtual visits between residents and their families. Those are just examples of the kinds of measures that I hope that may reduce the number of flags, those white markers that Pastor Collins places every morning in front of the First Congregational Church of Greenwich. We owe it to our seniors. We owe it to all of our families and all of their loved ones that we do better in our nursing homes. Thank you, Madam Chair. The Chairman. Thank you, Senator. Senator McSally? Senator McSally. Thank you, Chairman Collins. I want to echo Senator Scott's comments about your leadership and your passion for seniors, for small businesses under your leadership in this unprecedented challenge, so thank you, and thank you for this important hearing and to our witnesses for their testimony. In Arizona as of last night, there have been 747 deaths related to coronavirus, from the coronavirus, and 593 are over the age of 65, so that is about 79 percent. As I think about this, this is a cruel virus, as we all know, and it is the cruelest to our most vulnerable, and this is the greatest generation we are talking about. this is our opportunity as we learn more about the virus. We did not know a lot about it, but as we are learning more about it, for us to do everything we can to protect the greatest generation. This is our generation's opportunity to give back to them and there has been an important focus on nursing homes for the vulnerable who are in these congregate settings, but we also need to think about those in memory care, those in assisted living, those who are older but in independent living. My mom is 85. She is in good health for her age. She is in independent living, but she also has been isolated for now 2 months because she is just as vulnerable as others from this cruel disease. I have neighbors and constituents who are sharing their stories of their loved ones who are in these settings, and we need to make sure that we protect them. As I think about going forward--and it is not a choice of are we going to continue to protect lives or allow people to safely return to work. As we move forward, we can do both, but for seniors in congregate settings, we need to put a moat around them. We need to ensure that we have high levels of situational awareness, that anybody who goes to work there, supports there, or at some point visits there, that we know that they are not inadvertently bringing the virus in with them. We now know, unlike several months ago, that people can asymptomatically be carrying the virus, so checking temperatures is not enough. I thank you for the testimony today, but I want to look more broadly for all congregate settings. One of the challenges we have is where there is oversight of our nursing homes in Arizona, oversight from HHS, oversight at the State and county level, the independent living, the assisted living, they are usually private entities, and so they are trying to get PPE, trying to get testing. It is not an easy top-down thing to do with the supply chains. We have had many innovations in Arizona. One company I visited, AmSafe, used to make seatbelts and airbags for airplanes. They just started making masks and gowns to support our nursing homes in Arizona. It is just an incredible story. More of that needs to happen. We need to bring the PPE manufacturing home. I want to ask Dr. Konetzka, can you share broadly, if we are looking at all seniors in these congregate settings, what does it look like for us to keep that moat around them? I think it is our testing needs to be focused on staff and ideally visitors and others who are going to go in there and high levels of situational awareness, plus the controls that we have learned to isolate and be able to treat quickly but what does that look like, not just for nursing homes, but for everyone who is in this vulnerable category in a congregate setting? Dr. Konetzka. First, thank you very much for that question because I think there is a tendency to focus only on nursing homes, and in many States, assisted living facilities look very much like nursing homes in terms of the level of care needed and provided and the vulnerability of the residents, and yet because assisted living facilities are licensed by States and do not receive generally a lot of Medicaid or Medicare funding, we sort of tend to ignore them in these situations and yet they are completely just as vulnerable. I think your question about the social isolation in these settings, not just assisted living, but also independent living, is a huge challenge. I think the at the riskiest time when we have to prohibit visitors, some things can be done in the meantime like making sure that these facilities have appropriate technology so that residents can at least communicate through Facetime or other video chats with their families on a regular basis. In the longer run, I think it is essential for all the reasons that you and others have mentioned that we do worry about the social isolation and start allowing visitors, and that is one of those things that I think we will learn as we go in terms of how much is too much, but that balance has to be struck. We have to limit that social isolation even as we try to stem the virus. Senator McSally. Thank you. I know I am over my time, but I also want to say this. Isolation, I have heard cruel story after cruel story--the virus is cruel--of people fighting for their lives alone and the amazing nurses who are with them, but not with their loved ones and family members, people taking their last breath alone without their loved ones and family members, not being able to even be there for their funeral. We have got to be able to focus on allowing people when we can as quickly as possible to be with their loved ones safely during these times so that they can be there. It is impactful not just for the senior, but also for the other family members who feel helpless, so working together, we have got to address this issue to allow people to safely be able to visit at the right time. Thank you. Thank you, Madam Chair. Thank you for your grace. The Chairman. Thank you, Senator. Senator Gillibrand has fixed her technical problem, and she is next. Senator Gillibrand. Thank you, Madam Chairwoman. I appreciate this hearing very much. In my State of New York, the most terrible horror stories are coming out of our nursing homes, and a lot of the people who have lost their lives have lost them in nursing homes. One of the concerns I have is for the workers who work there, and if we had had national paid leave in place at the beginning of this, then any worker who had to take care of a family member or was sick themselves or had a child home would have been able to keep their job, keep their health care, and take up to 3 months leave, so that the length of the schools being closed or the length of an illness or sickness within their family, and without that, we have no safety net that would structurally be there for our workers when they have this kind of emergency, and this pandemic is a perfect example of how it could have been used more effectively. I want to ask Dr. Konetzka, do you agree that if workers, especially nursing home and home health workers, were allowed to consider their health or the health of their families by having access to a comprehensive paid leave program that that could better protect their patients and clients to slow the spread of the virus? Dr. Konetzka. I think a national paid leave program could help in a number of ways. I think in a broader sense, providing paid leave for health care workers and long-term care workers would allow them that flexibility, as you just mentioned. It would also allow perhaps other people the choice of taking care of their appearance or another family member instead of putting them in a nursing home, so I think it would affect all kinds of decisions at the margin. Under this particular crisis, I think we would still have a staffing shortage because people leaving and having the paid leave to take care of family members as they need does not help with staffing in nursing homes, so I think there are two sides to that. Senator Gillibrand. Yes. The other concern I have is that our nursing homes are still struggling to get access to testing and PPE, and we know that nursing home workers and people they serve are among the most vulnerable around the country. Both Dr. Landers' and Dr. Konetzka's testimony reinforce the need for an essential workers bill of rights to protect our essential workers, including nursing home and direct-care professionals during this public health emergency. Every essential worker in our country should have access to safety and health protections. They should have access to frequent testing and PPE. They should have more robust compensation. They should have paid leave. They should have universal sick days. They should have the kind of support that they deserve because they really are our frontline workers in this pandemic. Dr. Landers, do you believe that the health outcomes for patients are improved? Do we have high-quality, well-paid, and well-protected direct-care professional workforces? and do you agree that we need Federal investment in direct-care workforce? Dr. Landers. Senator, thank you. The aging care, home care, nursing home care, it is all about people caring for people. That is really what matters. People need that tender loving care, and to the extent that we have a strong, well-trained, well-supported workforce, the outcomes are going to be better for patients and families. I do believe that, and I am concerned about the shortages, shortages of nurses in particular, because I hear our nursing schools are turning away half of the qualified applicants, even though we have 80 million aging older adults, so I am thankful that you and your colleagues are thinking about the workers. Senator Gillibrand. I have one idea that I would like anyone to comment on. For the shortage of health care worker and home health workers and workers in nursing homes, one of the things I think we should be doing is having a health force, where we train a million workers in the next 2 months to do the contact tracing, to do the testing, and to do eventually vaccinations. For any on the panel, do you think training up this health force in the next 2 months would be able to help us have health care workers for the future so you would not have shortages for people who work in health care for our older adults, whether it is in direct care or whether it is in an assisted living facility? You can each give an opinion on that. Dr. Mulligan. Thank you, Senator Gillibrand. I do think that having resources in place in advance of future crises is absolutely what we need. What we find is if we are not ready ahead of time, when we chase our tails, so we do have to invest in advance in order to be ready when the crises come in the future, so having a group of young people who might then get very inspired by the work that they are doing and go on to become full-time, lifelong medical professionals, health care professionals, I think that is a very inspiring thought and something we should aspire to. Dr. Landers. Senator, I think, absolutely, getting new people into the workforce in these caring fields is really important, particularly home health aides and personal care workforce. There is definitely a need for more people to enter that field. Things like nursing, I mean, the nurses really are the keys to a lot of these teams, and we need really smart bachelor- prepared nurses, and that is something that is going to require more long-term policymaking, so that going forward that we are in a better position because those cannot be created overnight, same with primary care physicians and geriatricians, but in terms of the frontline personal care, funding could help with that. Senator Gillibrand. Thank you. Dr. Konetzka? Dr. Konetzka. I will just add that I think it is a really good idea for both the short term and the long term. It seems like something where it could help with the urgency of this situation to increase staffing in nursing homes and in home health, and it could help with the pipeline problem in that we just do not have enough people coming out of training programs wanting to work in long-term care and getting people interested early on. Even as we try to improve the working conditions so that they want to stay in it is a good idea. Senator Gillibrand. Thank you, Madam Chairwoman. The Chairman. Thank you. Senator Braun? Senator Braun. Thank you, Madam Chair. I want to echo what Senator Scott said. I am on several committees here in the Senate, and I think the best hearings have been in this Committee because you generally pick a topic that needs to be talked about at that moment in time, so thank you. The Chairman. Thank you. Senator Braun. I have got several questions teed up. As a business guy and entrepreneur, when I look at trying to apply the skills that work there, generally, you need to be agile. You need to think out of the box. You need to do things differently if you are going to be successful in a market. I am interested because we have made the case that disproportionately nursing homes have been impacted. What has been the rate of improvement in these few months that we have been grappling with it? Have we seen the rate of infections and deaths come down, or are we still at a level that I know is bad, but have we seen any improvement? and then the corollary with that would be, what best practices, what things have we seen in the successful nursing homes that would be maybe of key importance, one, two, and three? so has the rate improved, and then what best practices have surfaced in this time we have been tackling it? Any on the panel, feel free to jump in. Dr. Konetzka. I will be happy to start with that. I think the answer to your first question is we do not quite know because we do not have great data yet. Even for our study, we had to sort of pull State lists off the Internet and do a lot of data cleaning to make sure that we were analyzing something valid, and without the data to really know exactly where the infections and cases and deaths are, we will not be able to really answer that question. I suspect we are still learning as we are going and that many areas will still see outbreaks in nursing homes. For your second question in terms of best practices, I do think there are a few things we have learned, as I mentioned earlier. Testing everybody in a nursing home on a regular basis, to prevent asymptomatic spread, and then separating residents as possible into COVID-and non-COVID-positive parts of a facility, I think has been successful in many places. Dr. Landers. Senator, I think that---- Dr. Mulligan. Senator Braun--go ahead. Dr. Landers. I just want to say to the Senator that we are seeing in the home health setting over time that it seems like the rates of infection of our treasured workforce, it does seem to becoming less common week by week. These are people working in the hardest-hit areas of northern New Jersey where we have seen some of the highest levels of infection in the country. I do think week by week, the social distancing measures, the PPE, the expanded testing which still needs to expand further, but we are certainly in a better spot than we were in, in early March, where there was nothing, so we have a long ways to go, but the screening and education of the workforce, making sure they know when and how to ask for help and when to get them out of the workforce, and then also the testing programs for the workers is increasingly important. Dr. Mulligan. I think, Senator, the only thing I would like to add--and this gets at the innovation piece--is the research, the clinical trials. I agree with what my fellow panelist said about what we should be doing immediately in terms of implementing what appear to be best practices. In addition, we have to invest in research as a Nation supporting the NIH and doing the clinical trials that will help us get out of this thing as a whole, but in doing that, we will support the seniors. For example, one of the Senators talked about--Senator McSally--making a moat around our seniors. It made me think about herd immunity. If we can vaccinate the population broadly, even if seniors do not respond as well to vaccines, get the population immune. Then the workers who often bring the virus into nursing homes, this will not happen because they will have been protected and would not have become infected, so investment in clinical research. Senator Braun. Thank you. This one will be for Dr. Landers because I think as we debrief this over time, finding out what works, these best practices, but we have noticed that in Florida where arguably you might have the most vulnerable populations, is there something there that we can glean? I think the laboratory of States gives us a much better way to learn than maybe that one- size-fits-all site. The CDC, when we first looked at testing, cost us 30, 40, 50 days because of that focus on just one way. Is there something there in Florida that anybody can weigh in on? Dr. Landers, do you think that this will speed the move from nursing homes to home care over time? It seems like you are probably more safe in your home than you would be in a place that has got a lot of folks in the same building. Dr. Landers. Thank you, Senator. There is no question that there is increasing interest in home health care, and I have been in several living rooms, quite frankly, in the last couple weeks with families who have brought family members home from facilities to continue their recovery at home. They have been relieved and happy to get the home health and visiting nurse support, which is really critical for them being able to come home. In terms of the differences in different locations, absolutely, there are--we have seen geographic variations, and we should try and learn from those. Living in New Jersey, a lot of the people we serve actually travel between Florida and New Jersey. It is a fairly common consideration for snowbirds and such, and a lot of the questioning we have gotten has been around can people come back for their--you know, those people that are fortunate enough to be able to travel as such and is it safe. We are all interconnected, but at the same time, there are differences. We will have to learn from this going forward. Senator Braun. Thank you. The Chairman. Thank you. Senator Warren, I do not know whether you heard my opening remarks, but I do want you to know that I know I speak for every member of this Committee in expressing our condolences to you. You have been touched very personally by this virus, so welcome. Senator Warren. Thank you so much. I appreciate it, Madam Chair. You reached out to me personally right after my brother died, and he died in a comforted setting facility, in a rehab, so thank you. I appreciate it, and I very much appreciate that you are holding this hearing today. In fact, what I want to talk about is I want to talk more about how seniors are bearing the brunt of COVID-19. Nursing homes have become the epicenter of the crisis, and it is important that we do everything we can, that there is testing and that there is contact tracing, and that we get a vaccine, and that we develop treatments. One of the things we need to do is collect more data. I want to start by asking Dr. Konetzka, Why is it so important that nursing homes collect and report, in a timely manner and transparently, data about COVID-19 infections? Dr. Konetzka. I think it is critical for several reasons. One is just that we need to know where to direct resources. Nursing homes need help when they are having an outbreak, and so we need to know that right away. It also gives us a signal about what is happening in the communities in which nursing homes are located. Second, it will enable us to do research that will help us later figure out what worked and what did not work so that we can perhaps do better the next time. Finally, it is really critical for consumers. We have been encouraging consumers since 2009 to get on Nursing Home Compare and look at information for their nursing homes good care, but right now, they cannot easily find which ones have COVID outbreaks. We would like to give them that information so they can make good decisions. Senator Warren. Thank you. I think that is really important. It is such a serious issue. In Massachusetts, for example, more than half of the COVID-19 deaths are directly linked to long-term care facilities. Now, the Center for Medicare and Medicaid Services, the Federal entity that regulates nursing homes, is taking some important steps to ensure better data, and just last month, as you may know, CMS started requiring nursing homes to report new COVID-19 infections, outbreaks, hospitalizations, and deaths directly related and they have to report it to the CDC. Nursing homes also must notify residents and families of these infections. Nursing homes are not the only facilities, long-term care facilities that have been hit hard by this pandemic. Roughly 800,000 Americans live in assisted living facilities. In Massachusetts, about two-thirds of assisted living facilities have reported COVID-19 infections. Now, residents in assisted living facilities that serve older Americans require less frequent medical care than those in nursing homes and less help with activities for daily living, but populations in both places are similar, older people who need some help from caregivers in order to conduct daily tasks. Dr. Mulligan, you have been serving on the front lines of the coronavirus pandemic. When it comes to the patients that you have seen, does coronavirus affect nursing home residents any differently from how it affects assisted living residents, or are people living in both settings vulnerable to the crisis? Dr. Mulligan. There is no question that they are both very vulnerable. I think the assisted living facility and even the community dwelling seniors are at equal risk. If you think about a third of deaths are nursing home residents, but 80 percent of deaths are in seniors, that means there is an equal number to the nursing home deaths that are outside the nursing home. Senator Warren. That is right. Dr. Mulligan. Absolutely, Senator, you are correct. Senator Warren. Okay. That is really important. The reality is this virus does not care whether seniors are living in assisted living facilities or living in nursing homes. It can affect them, regardless. Let me go back to you, Dr. Konetzka. Are assisted living facilities required to report the same coronavirus information as nursing homes like report on infections or hospitalizations or deaths or outbreaks to the Federal Government and to the families and to the people who live there? Dr. Konetzka. No, they are not. Just like data collection and long-term care, generally, we do not collect much data from assisted living because they are not as dependent on Federal funding. Under the CMS guidance, as I understand it, we are also not collecting information from assisted living facilities, which for all the reasons you mentioned is unfortunate. Senator Warren. Yes. Assisted living facilities have similar populations as nursing homes. They face similar infection risks, but they are not subject to the same regulations when it comes to the coronavirus, and that is why I have launched an investigation with Senator Markey and with Congresswoman Maloney into how assisted living facilities are tracking coronavirus infections and preventive measures at these facilities and whether they have enough preventive measures in place. Assisted living facility residents and their families deserve to know whether or not their facilities are experiencing a coronavirus outbreak just like nursing home residents are entitled to know that, so I believe we owe it to our seniors to get this done. Thank you all for being here today, and thank you again, Madam Chairman. The Chairman. Thank you. Senator Rick Scott had to leave and go preside. He had joined us remotely. Now we still turn to Senator Doug Jones. Senator Jones. Thank you, Madam Chairman. Thank you very much for holding this hearing. I appreciate it, and thanks to all of our panelists for this very, very important hearing. I kind of want to followup a little bit about not just the assisted living but nursing homes in particular. My mom is in an assisted living, so it has been a challenge for all of us and especially her over the last few weeks. We lost dad in December. The isolation has been a struggle. We lost dad to Alzheimer's, and I think it has been particularly tough on Alzheimer's patients and caregivers. Those forms of dementia create special problems, regardless, it has been said. To listen to my mom, she has been talking every week. She will mentioned that as much as she misses my dad who she was married to for 70 years, she is also somewhat thankful that he passed before all of this pandemic hit. In part, I think that is because of the problems that she would have faced. She used to go down and visit him every day, and that is especially troubling. My friend, John Archibald, who writes for al.com, wrote an article this week called ``Coronavirus Creates a Special Hell for Dementia Caregivers,'' and he talked about trying to imagine what it is like for an Alzheimer's patient or caregivers. Imagine what it is like to try to explain social distancing to a person who does not share the reality, and he quotes Pam Leonard, who is a program director in Birmingham of the CJFS CARES program. She talks about caregivers and said that it is kind of like being on an airplane. You got to take care of yourself. You got to put on your own oxygen mask before you are able to help those around you. I would like to get to anyone on the panel. Given the special and unique needs and challenges that we are seeing, what can we do to more support individuals with dementia, both in these facilities and out, and their families and caregivers, and are there special trainings that might be needed for any of these long-term care and dementia facilities in a situation like we are in now which we have not seen before, but we could see again? I will open it to anybody. Dr. Mulligan. Senator Jones, I really think that you have touched on something so important. I think as a society, we will always be judged by how we take care of the most vulnerable, and certainly, our dementia seniors at this point are among the most vulnerable. They are not able to express, for example. If they are becoming ill, they would not necessarily be able to express that they do not feel well, that they feel hot, that they are short of breath, et cetera. They have medical as well as the sort of psychological, emotional vulnerabilities at this time of this pandemic that are unique to them, I think. I do not know that I have any specific answer for you, but I would encourage any effort to bring together a think tank to brainstorm about this. I think it is absolutely needed, and thank you for raising it. Dr. Landers. Senator Jones, thank you for raising this critical issue, and I share your deep concern for the well- being of people living with dementia. Actually, one of the sad parts about all this has just been hearing my staff explain what is going on when they are doing nursing visits with older adults with severe dementia. In cases when they have had to do a test, those nasopharyngeal swab tests, for example, that has in some cases been fairly traumatic and upsetting even to do the test because the person just does not understand. One thing in assisted living and independent living, because that has been a big topic in this hearing, we should point out home health agencies are able to come into those settings, as are hospice agencies in certain instances, to buttress the care in those facilities, so to the extent that we continue to have a strong home health option and focus on the things that Senator Collins is focused on around telehealth, I think that is going to strengthen dementia are and assisting living and also encouraging people to focus on goals of care and family caregiving plans also can help, but really tough issues we are facing. Senator Jones. Great. Well, thank you. Thank you very much, both of you, for that. Dr. Konetzka, real quick, as my time runs out, your research has indicated that racial and ethnic minorities and low-income individuals have been disproportionately affected with nursing homes that have larger minority populations, more likely to have coronavirus cases and deaths. I think there is an article about that also in the New York Times. Could you briefly share more about what factors might contribute to those disparities? Dr. Konetzka. Yes. Thank you for that question. Disparities in nursing home outcomes from COVID are not unlike disparities we see across the health care system, and it is the result of many years of differences by race in health infrastructure and resources and risk factors of populations. What we found in our research was not necessarily that nonwhite residents were more--were having worse outcomes within a facility. It was about the percent white in a facility. To me, it is really about the neighborhoods in which nursing homes are located and staff going back and forth between those facilities and the neighborhoods. I think it is a lot about where the virus is circulating and who is in those facilities and who is going back and forth. Senator Jones. All right. Well, thank you, and thank you, Madam Chairman, for holding this hearing. It is very, very important. Thank you. The Chairman. Thank you, Senator. Senator Rosen. Senator Rosen. Thank you, Senator Collins, for holding this very important hearing. It is incredibly sad to see what is happening in our nursing homes and our assisted livings, what is going on with our caregivers across our country. I was a caregiver for my parents and in-laws. I understand this from a firsthand perspective, and it is overwhelming, frightening, and frustrating particularly at this time. One thing that I think we really need to focus on is research, research to fully understand how this virus works and how to best treat and prevent it. It is so critical. I recently introduced legislation with Senator Rubio, the Ensuring Understanding of COVID-19 to Protect Public Health Act. It is going to require a longitudinal study of COVID-19, including individuals of all ages along with diversity in race, ethnicity, gender, geography, underlying health conditions. We need to understand why the virus impacts some people like our seniors differently than others. We need to understand what the presence of antibodies really needs, if seniors or others who get sick gain an immune response or not. That is the theory that they gain an immune response, but reports of groups of patients becoming ill a second time is really concerning, and there has been recent reports, of course, across that group of sailors on the USS Theodore Roosevelt getting reinfected. Dr. Mulligan, I have a two-part question. Do you know what the latest research is, or can you talk about it, the latest research that is following patients who are diagnosed a second time with coronavirus, including seniors? this could have a further impact on our senior living centers. Do we know if this is a brand-new infection or if this is the original infection making them sick again, and what do you think this information might have? What impact might it have on vaccine development? Dr. Mulligan. Thank you, Senator Rosen, for this question. I do think that the jury is out in terms of formal proof that having recovered successfully, one is immune. Certainly, most people that recover make antibodies. We have seen that in our own studies, and many others have reported that. With most viral infections, it is true that once you have had it, you are protected at least for a period of time. I personally expected that should be true here as well. The formal proof of that will be done in studies such as you described, and I think that is a fantastic study. We are entering a time point where we have more and more convalescent patients, and now we can study how they do over time. I think the jury is out on these reports of possible reinfections that may well represent an intermittent negative test than a positive test that occurred as a result of their original infection. We know that can occur. The test is not perfect, and so that would not surprise me if that was the cause of some of those, but the jury is out, and for vaccine development, it is the same. I am a scientist. I want to know what the evidence says. If we do our studies correctly, if we are well supported, we will get the truth. We will get the answer, and that is what science will do for us. Senator Rosen. I want you to also--in your testimony, you said that medical countermeasures may need to be tailored to seniors in order to optimally protect them. Would you expand on that a little bit in a minute or so that I have left, please? Give us some good examples. Dr. Mulligan. Sure, I am very happy to do that. Maybe the most prominent example is that we have a couple of special vaccines for flu for seniors. We have a high-dose vaccine. We have a vaccine with adjuvant. We know, as I said, seniors' immune systems are weaker, and they do not respond as well to vaccines. Having a stronger vaccine, one with an adjuvant, one with a higher dose, may be necessary for COVID-19 in seniors as well. We need to do those kinds of special studies. We also want to be sure that treatments are tolerated well and are safe in seniors. Their system is different, and so we need to be sure to include seniors in our treatment studies as well as our vaccine studies. Then another great example is the monoclonal antibody approach. If a senior cannot make a nice antibody themselves, perhaps we can infuse the antibody, this monoclonal antibody drug, and that is something that is going to be explored in the nursing home setting, and I think is very important. Senator Rosen. Well, I thank you and all the other witnesses for your work, your passion, your commitment. We really need you. We thank you all. We are very thankful you are doing what you are doing, and please stay well and safe. Thank you. The Chairman. Thank you, Senator. Dr. Mulligan, I want to followup on the questions you were just asked by Senator Rosen about your work on vaccines, and you have made the very important point that older adults sometimes do not respond as well as younger adults to vaccines, but that vaccines can convert this herd immunity that can help protect seniors. You have also distinguished about different kinds of vaccines. Could you describe to us the two vaccine trials that I understand you are currently involved with and whether or not you have seniors enrolled in those trials? Dr. Mulligan. Sure. Thank you, Senator Collins, for the question. We are currently conducting a Phase 1 trial in healthy younger adults, age 18 to 55, with one candidate vaccine. As soon as we see in this trial that the vaccine is tolerated and safe in these younger adults, we will go to a second group, including seniors. It is not unusual in medical research to make sure in the first in human studies that the new treatment or vaccine is safe and well tolerated in healthier younger adults before you go to a more vulnerable population, which might be seniors or children or pregnant women. We will quickly move to seniors in the trial we are currently conducting at our university. The second trial is a very large efficacy trial that will be launched in July supported by the U.S. Government, NIH, in collaboration with the vaccine that had the very promising early report, earlier this week with that company. That trial will be for adults aged 18 and older. From the very beginning, that efficacy trial will include seniors and will do so at a significant proportion. At least a quarter or more will be seniors as it is currently planned. The Chairman. That is very encouraging to hear. Could you also talk a little bit more and explain to us the fact that you could have the monoclonal antibodies approach? It is my understanding that when you give a vaccine, it is usually with a live virus, and then your body produces the antibodies that would allow you to fight off exposure to the virus later on, but if you use the--are you suggesting that an alternative approach is rather than injecting the virus, you would inject antibodies? Is that correct? Did I understand that correctly? Dr. Mulligan. Yes, Senator, you did. The standard approach is known as ``active immunization.'' We deliver a vaccine, which might be a weakened virus. It might just be a protein, a piece of the virus. It could be RNA, as was reported this week, and we ask the body to produce a bit of the vaccine protein and make an immune response, make the antibody. Seniors are not as good at doing that, and so an alternate is what is called ``passive'' rather than ``active immunization.'' In that case, you actually infuse the antibody, and the antibody has a half life of a month. There are ways to tweak it where it could even last for a couple of months. It is an interim approach, perhaps, to get us through the worst of this where we could protect our very vulnerable seniors, and it has to be tested in a randomized control trial. The Chairman. That is fascinating. Where are those antibodies produced? Are they taken from individuals who have already had the coronavirus, or are they manufactured, if you will, in a lab? How are they produced? Dr. Mulligan. Yes. Thank you. It really is fascinating. I will give you one example. Actually, the first human in the United States to come down with coronavirus, his antibodies were cloned by a company and created--converted in a laboratory to a drug. You can mass produce the antibody molecules and then have that available for infusion into research participates in the future, so you take--and you pick an antibody, I should have said. You pick the antibody that is very potent at neutralizing the virus, so you pick basically the champion virus and then champion antibody, and then that becomes your monoclonal antibody drug for testing. The Chairman. Very interesting. Thank you. Senator Casey? Senator Casey. Madam Chair, thank you very much for the hearing and also for the brief second round of questions. I just have two. I want to start with Dr. Konetzka. I had mentioned earlier the wait lists, the 800,000 individuals who are on waiting lists for both services and supports in their homes and their communities. I get that number from Kaiser Family Foundation. It is an awfully big number. That number did not arise since the crisis began. That has been a number that predated the crisis, but I want to emphasize these are people on waiting lists that qualify for services but there is insufficient funding to provide those services. We have some States, I know, that are increasing pay for direct-service providers, and that is one of the steps we should consider. I have a bill that would encourage every State to do what some States are doing, which has served as a foundation for the enhanced matching dollars the Federal Government provides for Medicaid in their recent legislation. Dr. Konetzka, can you explain the importance of addressing these wait lists for what is known as home-and community-based services in the context of the current pandemic? Dr. Konetzka. Thank you. I would be happy to talk to that. First, I should note, though, that interpreting these wait lists is a little bit difficult. These are wait lists for home- and community-based care waiver programs under the Medicaid program, and each State does it a little bit differently, so 800,000 sounds like a lot, but in some States, they just do not use wait lists. We may be underestimating the people who actually need services there. In other States, they do not assess people for eligibility before putting on the wait lists, so the wait lists are huge in those States. That aside, I think we can certainly agree that there are probably many more people who could benefit from these services that are getting them, and during this crisis, I think it is absolutely essential that we do what we can to try to enable more people to get those home-based services because the risks of entering a nursing home right now have just grown astronomically, so enabling more home-and community-based care right now may really save lives. Senator Casey. Thank you very much, Doctor. The last question I have is for Dr. Landers. I just want to go back because I was jotting down numbers before, and I think I missed one of the numbers in your testimony. It is regarding the personal protective equipment, PPE. You had indicated, I thought, that you needed for just a week, 17,000, and I was not sure what that was. If you could repeat those numbers, because one of the real failures--and this is a colossal failure--of the PPE is not simply that we have all kinds of instances where there is not enough in care settings, not to mention first responders and other circumstances, but what is going to happen in the months ahead? It is not just a question of what we need for this month or next month, and I think we do not have a sense yet of the numbers, the scale of the problem. I guess I just wanted to give and provide an emphasis on one provider or one care setting and what you need. Dr. Landers. Senator Casey, thank you. Yes. Our current kind of ``burn rate'' is kind of the term that is being used in terms of how fast we are going through PPEs as a company is that just over 17,000 of the surgical masks and then over 3,500 of the N95 masks every week. When I look to our chief operating officer and chief financial officer who are responsible for procuring this stuff, that is kind of what they are trying to find on the market with various vendors. It still remains a challenge for them to track down enough vendors. I am thankful that you are considering that going forward because it is an ongoing issue, and that is who we are able to continue to serve is by having that protective equipment. I actually did a home visit. It was a little bit warm last week. I was in an apartment building that was not very well ventilated, and I was sweating, and I was realizing, oh, I need to change my mask because the mask is getting soaked, so we do have to remember that sometimes these get soiled. There is a lot of need there, and so thank you for looking out for that issue. Senator Casey. Thank you. Thank you, Chairman Collins. The Chairman. Thank you very much, Senator Casey, and I would second your concern about the availability of PPE for our home health agencies. That has been a problem in the State of Maine as well that I have been working on personally to deliver some PPE to our home health agencies. It is something that is very difficult for them to do their jobs without it. I want to thank our terrific witnesses for being with us today and for their work and their research. It really makes a difference. I want to thank the staff for figuring out how we can safely hold this hearing and observe social distancing, which we did throughout. I would note that virtually every member of the Committee joined the hearing either in person here in the hearing room or remotely, and I am very pleased with that. I think it shows how much people care about this issue. I also want to give a special shout-out to the technical experts who made this possible. When you have that many Senators who are joining us remotely, Senators who are joining us here, and witnesses in three different places in the country, it is amazing to me that our technical experts were able to make everything go so smoothly, and I thank them. This week, the overall death toll in the United States from the COVID-19 virus surpassed 90,000 people, 80 percent of whom were older adults. This means that we have lost more than 72,000 older adults to this pandemic. At the beginning of this hearing, I remarked on the enormous challenges and tragedy that COVID-19 has brought to our country. It has also brought countless examples of great courage and selflessness from those on the front lines of this pandemic, including our medical personnel and our direct-care workforce, but they are not the only ones. We see it at the grocery stores. We see it with those who are stocking the shelves and running our gas stations and other essential businesses. We see it as those as I have seen in the State of Maine who are making the swabs in rural Maine that are essential for our testing. We see it all over our country as people step forward and businesses step up to convert their lines and do their part. I appreciate all of that sacrifice, that compassion, that effort. I also want to pay special tribute to our witnesses today. I thought they were absolutely excellent and really increased our understanding. Dr. Mulligan's leadership on vaccine development helps advance tangible medical countermeasures for those most in need, and I appreciated his giving us a great education today. Dr. Konetzka's research helps us better inform our efforts to protect the residents not only of nursing homes but of assisted housing that our seniors have and other congregate care facilities. Dr. Landers focused on home health care, which has always been a special passion of mine, and technologies such as telehealth which helps us to improve care of older adults in their own homes, and after all, that is where most older adults want to be. They want to be in the privacy, security, comfort of their own homes if they can be. This Committee will continue to explore potential solutions to the challenges discussed in this hearing as well as other impediments to the health and safety of our Nation's senior. This week, members of the Aging Committee introduced a resolution to designate this month as Older Americans Month. As we work to improve care for older adults amid this pandemic, we also should take the time to recognize our seniors as valued members of our society, our culture, and our lives. The health and well-being of seniors strengthen our Nation as a whole and is the very mission of this Committee. Senator Casey, I would like to call upon you for any closing comments. Senator Casey. Chairman Collins, thank you for convening this hearing on such an important topic, and I am grateful for the opportunity that we have had. I am certainly grateful for the testimony of our witnesses who bring to bear a degree of expertise and experience with these issues that are so important to families when it comes to caring for our seniors in all settings, and we are grateful that the witnesses are with us today, and I know there will be even more followup. I do want to thank and reiterate what Chairman Collins said about the staff. This is a technical challenge, and they helped all of us through this. We are grateful for their good work, as we always should commend the staff in the Senate who do such good work and especially under these circumstances. We also want to thank, of course, as we all have in one way or another, all of the health care and home health workers throughout the country, service providers as well, caregivers for caring for our aging loved ones all the time but especially during this terrible virus, which has caused such devastating across the country. We owe all of those workers a debt of gratitude. I think we should do more than just say thanks. We talked about pandemic premium pay and other ways to reward their work because they are not just frontline workers. In many cases, they are at the front of the front line, exposing themselves and putting themselves at risk, and our Nation should reward them as we did returning soldiers from other battlefields in our history. Congress has done a number of things to help seniors in the four pieces if legislation that have been passed, but I would argue not nearly enough, not nearly what we must do for our seniors. That is why we have to keep acting legislatively. I am frustrated, as I know a number of Senators are, that we spent virtually the whole month of May on nominations and not voting on COVID-19 policy or appropriations, and unfortunately, we are going into June with that same setting or that same circumstance in the Senate. I think we should be voting--if we are going to be here and voting every week, we should be voting on COVID-19. That should be the top priority and, of course, the economic consequences that flow in the wake of this terrible virus, so we have more to do. We certainly need to do more on testing nationally. I think the administration should outline a strategy at long last. We mentioned personal protective equipment for our frontline workers. We cannot talk about or work on this issue enough. There is just no way to comprehend that in a Nation as powerful as ours, a Nation that was able to produce the armaments and other production capacity to win World War I and all the wars in between, including World War II, the idea that that same Nation cannot produce enough masks--masks or gloves or personal protective equipment for everyone that needs it is really an appalling--it is an appalling failure and we have to worry about the next couple of months. I know that as of eight o'clock this morning in the State of Pennsylvania, 64,412 cases, the death number in Pennsylvania is now 4,767. That is only for March, April, and May. I do not want to be sitting here in December because we did not do enough on testing and personal protective equipment and find out that another 4,700 or 5,000 Pennsylvanians have died. We need the productive capacity, and we are not doing enough as a Nation. The Federal Government has to demand that we set forth the production capacity on PPE. If we could do it in the past to win wars, we can do it now to win this war, and the administration has to do a lot more to make sure we can produce what we need, so we have a long way to go, lots more work to do, lots more legislating and appropriating, but we are grateful, Chairman Collins, for this hearing and thank you for giving us this opportunity. The Chairman. Thank you. Committee members will have until Friday May 29th to submit additional questions for the record. If we do receive some, we will pass them on to our witnesses. Again, I want to thank everyone for participating, and this hearing is now adjourned. [Whereupon, at 11:35 a.m., the Committee was adjourned.] ======================================================================= APPENDIX ======================================================================= Prepared Witness Statements ======================================================================= [GRAPHICS NOT AVAILABLE IN TIFF FORMAT] ======================================================================= Questions for the Record ======================================================================= [GRAPHICS NOT AVAILABLE IN TIFF FORMAT] ======================================================================= Additional Statements for the Record ======================================================================= [GRAPHICS NOT AVAILABLE IN TIFF FORMAT] [all]